Mid-Day Breakouts Report - Monday, September 11th, 2023

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Wednesday, October 23, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - MONDAY, SEPTEMBER 11TH, 2023
Previous Mid Day Report Next Mid Day Report >>>

DOW 34602.49 25.9 (0.07%) | NASDAQ 13838.69 77.16 (0.56%) | S&P 500 4471.66 14.41 (0.32%)

Time of Screening : 9/11/2023 12:20:16 PM Report Released : 9/11/2023 12:41:10 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AFYA - NASDAQ - Consumer Svcs-Education Afya Limited Cl A	$16.61	+0.60 3.75%	$16.87	$17.02	-2.41%	184,179 85.66%	215,000
Most Recent Note for AFYA - 9/11/2023 12:21:47 PM Faces resistance due to overhead supply up to the $28 level. Reported Jun '23 quarterly earnings +23% on +31% sales revenues versus the year ago period. Fundamental concerns remain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BCSF - NYSE - Financial Svcs-Specialty Bain Capital Specialty Finance	$16.06	+0.11 0.66%	$16.12	$15.97	0.53%	222,226 119.48%	186,000
Most Recent Note for BCSF - 9/11/2023 12:23:07 PM Perched at its 52-week high while adding to a spurt of gains marked by volume. Little resistance remains due to old overhead supply. Three of the past 4 quarterly comparisons through Jun '23 showed earnings increases versus the year ago periods above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a concern. Completed its $20.25 IPO on 11/15/18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BUR - NASDAQ - Food-Grain & Related Burcon Nutrascience Corp	$16.17	+0.26 1.63%	$16.38	$17.70	-8.64%	1,606,669 261.25%	615,000
Most Recent Note for BUR - 9/11/2023 12:23:56 PM Hit a new 52-week high with a big gain backed by heavy volume on the prior session. Noted with caution in prior mid-day reports - "Recent quarterly comparisons through Mar '23 showed strong sales revenues and earnings increases versus the year ago periods. Annual earnings history (A criteria) has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CRH - NYSE - Bldg-Cement/Concrt/Ag C R H Plc Adr	$54.80	+0.04 0.07%	$55.20	$60.72	-9.75%	2,007,184 108.03%	1,858,000
Most Recent Note for CRH - 9/11/2023 12:24:50 PM Recently broke below its 50 DMA line ($57.38) and on track today for a 6th consecutive volume-driven loss. Irish Building - Cement firm has an erratic earnings (C and A criteria) history. Fundamental concerns remain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GHM - AMEX - MANUFACTURING - Metal Fabrication Graham Corp	$16.17	-0.06 -0.37%	$16.29	$17.95	-9.92%	23,002 79.32%	29,000
Most Recent Note for GHM - 9/11/2023 12:27:59 PM Hovering near its 52-week high. Gapped up on 8/07/23 breaking out of a 5-month base. Quarterly comparisons through Jun '23 have shown great sales revenues and earnings improvement over the year-ago periods. Annual earnings history (A criteria) has been subpar.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HWKN - NASDAQ - CHEMICALS - Basic Chemicals Hawkins Inc	$56.51	-5.12 -8.31%	$61.77	$63.21	-10.60%	102,781 138.89%	74,000
Most Recent Note for HWKN - 9/11/2023 12:28:50 PM Pulling back from its all-time high with today's big volume-driven loss. The 3 latest quarterly earnings comparisons through Jun '23 versus the year-ago periods were below the +25% minimum guideline (C criteria). Went through a choppy consolidation above and below its 200 DMA line since dropped from the Featured Stocks list on 4/08/22.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HZNP - NASDAQ - Medical-Biomed/Biotech Horizon Pharma Inc	$115.38	-0.04 -0.03%	$115.48	$115.70	-0.28%	1,470,871 66.89%	2,199,000
Most Recent Note for HZNP - 9/11/2023 12:29:01 PM Reported earnings +12% on +8% sales revenues for the Jun '23 quarter versus the year ago period and fundamental concerns remain. Consolidating following M&A news. Up and down quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
KAI - NYSE - Machinery-Gen Industrial Kadant Inc	$219.13	-0.09 -0.04%	$220.45	$229.90	-4.68%	35,340 78.53%	45,000
Most Recent Note for KAI - 9/11/2023 12:30:04 PM Consolidating above its 50 DMA line and perched near its 52-week high. Reported earnings +13% on +11% sales revenues for the Jun '23 quarter versus the year-ago period, its 5th quarterly comparison below the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in FY '20 annual earnings (A criteria) history, not a great match with the guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LLY - NYSE - Medical-Diversified Lilly Eli & Co	$595.63	+9.17 1.56%	$597.96	$587.55	1.38%	1,879,544 68.10%	2,760,000
Most Recent Note for LLY - 9/11/2023 12:30:48 PM Hitting another new all-time high with today's 6th consecutive gain. There was a "breakaway gap" on 8/08/23 for a new all-time high after it reported Jun '23 quarterly earnings +69% on +28% versus the year-ago period. Fundamental concerns remain. Prior quarterly comparisons were well below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It was dropped from the Featured Stocks list on 8/11/22.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NATR - NASDAQ - DRUGS - Drug Related Products Natures Sunshine Prod	$16.62	+0.14 0.85%	$16.82	$17.25	-3.65%	36,716 79.82%	46,000
Most Recent Note for NATR - 9/11/2023 12:31:29 PM Erratic quarterly and annual earnings history (C and A criteria) leaves fundamental concerns. Perched near its 52-week high after volume-driven gains, consolidating well above its 50 DMA line and prior highs in the $14 area. Faces some resistance due to overhead supply up to the $19 level.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NGVC - NYSE - RETAIL - Grocery Stores Nat Grocers Vit Cottage	$13.41	+0.50 3.86%	$13.41	$13.95	-3.88%	21,222 66.32%	32,000
Most Recent Note for NGVC - 9/11/2023 12:34:20 PM Perched near its 52-week high. Reported earnings +82% on +6% sales revenues for the Jun '23 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) with subpar sales revenues growth.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NVO - NYSE - DRUGS - Drug Manufacturers - Other Novo Nordisk A/S Adr	$199.35	+3.95 2.02%	$199.68	$197.54	0.92%	1,822,270 111.05%	1,641,000
Most Recent Note for NVO - 9/11/2023 12:34:45 PM This Denmark-based Medical - Ethical Drugs firm is perched at its all-time high and on track today for a 6th consecutive volume-driven gain. Reported Jun '23 quarterly earnings +53% on +37% sales revenues versus the year-ago period, its 2nd strong quarter. Fundamental concerns remain. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ORCL - NYSE - COMPUTER SOFTWARE & SERVICES - Application Software Oracle Corp	$126.27	-0.05 -0.04%	$127.42	$127.54	-1.00%	5,519,808 69.44%	7,949,000
Most Recent Note for ORCL - 9/11/2023 12:35:33 PM Found support near its 50 DMA line ($117.53) while recently consolidating near its all-time high. Prior mid-day reports noted - "It faces no resistance due to overhead supply. Reported May '23 quarterly earnings +8% on +17% sales revenues versus the year-ago period. Earnings increases have not been strong and steady above the +25% minimum guideline (C criteria) in quarterly comparisons versus the year-ago periods. Fundamental concerns remain."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PHG - NYSE - CONSUMER DURABLES - Electronic Equipment Koninklijke Philips ADR	$21.59	+0.78 3.75%	$21.65	$23.30	-7.33%	1,006,427 99.74%	1,009,000
Most Recent Note for PHG - 9/11/2023 12:36:28 PM Reported earnings +108% on +4% sales revenues for the Jun '23 quarter versus the year-ago period, its 2nd strong quarter. Consolidating near its 50 DMA line. Faces resistance due to considerable overhead supply up to the $37 level. Fundamental concerns remain. Prior sales revenues and earnings history is below guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TSLA - NASDAQ - Auto Manufacturers Tesla Motors Inc	$271.62	+23.12 9.30%	$272.53	$313.80	-13.44%	98,329,410 85.45%	115,071,000
Most Recent Note for TSLA - 9/11/2023 12:40:32 PM Gapped up today rebounding above its 50 DMA line ($256.60). Fundamental concerns remain. Reported Jun '23 earnings +20% on +47% sales revenues versus the year ago period. Prior quarterly earnings (C criteria) history is not a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UBS - NYSE - BANKING - Money Center Banks U B S Ag	$25.62	+0.12 0.45%	$25.86	$26.97	-5.02%	2,284,698 78.43%	2,913,000
Most Recent Note for UBS - 9/11/2023 12:40:54 PM Slumped from its all-time high and it is consolidating. Reported Jun '23 quarterly earnings +999% on +53% sales revenues versus the year-ago period. Prior quarterly comparisons have been erratic, fundamentally below guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
YALA - NYSE - INTERNET - Content Yalla Group Ltd Ads	$5.16	+0.02 0.29%	$5.21	$5.77	-10.66%	157,316 67.23%	234,000
Most Recent Note for YALA - 9/11/2023 12:41:04 PM Fundamental concerns remain for this United Arab Emirates-based social networking and entertainment firm.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.